Stay informed with the latest updates for the inheritable blood disorders community. Industry Bayer Submits Application for Long-Acting FVIII CandidateSep 6, 2017 Industry Sangamo and Pfizer Announce First Patient Treated in Hemophilia…Sep 5, 2017 IndustryFDA Approves Additional Vial Sizes for Nuwiq®Sep 5, 2017 Industry Pfizer to Build Gene Therapy Facility in North CarolinaAug 17, 2017 Industry Spark Reports Preliminary Data from Hemophilia A Gene Therapy Trial Aug 14, 2017 Industry UniQure Escalates Hemophilia B Gene Therapy Manufacturing SiteAug 4, 2017 Industry BioMarin Reports Continued Progress in Clinical Trial for…Aug 1, 2017 Industry Octapharma USA Funds National Camp Exchange for Bleeding Disorders CampsJul 13, 2017 Industry Alnylam and Sanofi Report Positive Trial Updates for FitusiranJul 11, 2017 Industry Shire Submits IND Application for Hemophilia A Gene Therapy CandidateJul 10, 2017 Industry Genentech Announces Progress in Two Phase III Emicizumab StudiesJul 5, 2017 Industry FDA Approves Biologics License Application for Novo Nordisk’s…Jun 2, 2017 Industry Investigational Therapy for Hemophilia A Comes up Short in TrialJun 2, 2017 Industry Genentech Announces Positive Interim Trial Results for EmicizumabApr 17, 2017 Industry Grifols Increases Commitment of Factor VIII DonationsApr 17, 2017 Pagination First page Previous page … Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Page 14 Page 15 Page 16 … Next page Last page
